| 中文名 | 1,1'-[2-(苯基氨基)-1,4-亚苯基]二[1-[4-(1-吡咯烷基)-1-哌啶基]甲酮] |
|---|---|
| 英文名 | unc1215 |
| 中文别名 |
(2-(苯氨基)-1,4-亚苯基)双((4-(吡咯烷-1-基)哌啶-1-基)甲酮)
UNC1215,L3MBTL3 甲基赖氨酸结构域的拮抗剂 抑制剂UNC1215 |
| 英文别名 |
(2-Anilino-1,4-phenylene)bis{[4-(1-pyrrolidinyl)-1-piperidinyl]methanone}
UNC1215, 10 mM in DMSO UNC-1215 UNC 1215, >= 1,1'-[2-(Phenylamino)-1,4-phenylene]bis[1-[4-(1-pyrrolidinyl)-1-piperidinyl]methanone] [2-Phenylamino-4-(4-pyrrolidin-1-yl-piperidine-1-carbonyl)-phenyl]-(4-pyrrolidin-1-yl-piperidin-1-yl)-methanone UNC-1215 //BP UNC 1215; UNC1215 Methanone, 1,1'-[2-(phenylamino)-1,4-phenylene]bis[1-[4-(1-pyrrolidinyl)-1-piperidinyl] N-Phenyl-2,5-bis({[4-(pyrrolidin-1-yl)piperidin-1-yl]carbonyl})aniline UNC1215 1,1'-[2-(PhenylaMino)-1,4-phenylene]bis[1-[4-(1-pyrrolidinyl)-1-piperidinyl]Methanone] (2-(phenylaMino)-1,4-phenylene)bis((4-(pyrrolidin-1-yl)piperidin-1-yl)Methanone) 1,1'-[2-(Phenylamino)-1,4-phenylene]bis[1-[4-(1-pyrrolidinyl)-1-piperidinyl]methanone] UNC |
| 描述 | UNC1215是选择性MBT (恶性脑瘤)拮抗剂,与L3MBTL3结合,IC50为40 nM,Kd为120 nM。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 沸点 | 712.1±60.0 °C at 760 mmHg |
| 分子式 | C32H43N5O2 |
| 分子量 | 529.716 |
| 闪点 | 384.5±32.9 °C |
| 精确质量 | 529.341675 |
| PSA | 59.13000 |
| LogP | 3.37 |
| 外观性状 | white to beige |
| 蒸汽压 | 0.0±2.3 mmHg at 25°C |
| 折射率 | 1.640 |
| 储存条件 | 2-8°C |
| 水溶解性 | DMSO: soluble5mg/mL, clear |
| 危险品运输编码 | NONH for all modes of transport |
|---|